GlassScriptPhysician profile
Ashley E Vittum
NPI 1699366906
$1,302.18
in general payments reported to CMS, 2019-2025
14 companies · $88.74 in 2025
The $88.74 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $82.86 · 2023: $181 · 2024: $792 · 2025: $88.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.09 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $172.19 | 2023-2024 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.51 | 2023-2024 | Relistor |
| Valinor Pharma, LLC | $116.75 | 2023-2024 | Movantik |
| Teva Pharmaceuticals USA, INC. | $85.04 | 2021-2024 | Ajovy |
| Ibsa Pharma INC. | $66.01 | 2023-2024 | Tirosint, Licart, Tirosint |
| Scilex Pharmaceuticals INC. | $47.41 | 2022 | |
| Painteq LLC | $45.52 | 2024 | Painteq |
| Biodelivery Sciences International, INC. | $42.40 | 2021 | |
| Grt US Holding, INC. | $35.45 | 2022 | |
| Amgen INC. | $31.34 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.12 | 2025 | Entyvio |
| Amarin Pharma, INC. | $16.35 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Vittum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.